Thus, while CXCL5 appears to have multiple positive effects acting as a chemoattractant to promote PDAC tumorigenesis, it also appears to function in an autocrine manner, increasing pancreatic cancer cell fitness and viability. Here, CXCL5 is linked to pancreatic neoplasm.